Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone
AUTOR(ES)
Piller, Linda B
FONTE
BioMed Central
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=149403Documentos Relacionados
- Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT?
- Comments on ALLHAT and doxazosin
- Intensive Glucose-Lowering Therapy Reduces Cardiovascular Disease Events in Veterans Affairs Diabetes Trial Participants With Lower Calcified Coronary Atherosclerosis
- Company’s decision to lengthen lipid lowering trial causes controversy
- YOU CAN PREDICT YOUR HEART ATTACK AND PREVENT IT